We just received data on a new analyst forecast for $CVRX. Cantor Fitzgerald gave a rating of 'Overweight' for $CVRX.
$CVRX Analyst Ratings
Wall Street analysts have issued reports on $CVRX in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 08/05/2025
- Piper Sandler issued a "Overweight" rating on 05/09/2025
- JP Morgan issued a "Underweight" rating on 05/09/2025
- Lake Street issued a "Buy" rating on 04/08/2025
- Canaccord Genuity issued a "Buy" rating on 04/08/2025
To track analyst ratings and price targets for $CVRX, check out Quiver Quantitative's $CVRX forecast page.
$CVRX Price Targets
Multiple analysts have issued price targets for $CVRX recently. We have seen 5 analysts offer price targets for $CVRX in the last 6 months, with a median target of $12.0.
Here are some recent targets:
- Ross Osborn from Cantor Fitzgerald set a target price of $11.0 on 08/05/2025
- Matt O'Brien from Piper Sandler set a target price of $12.0 on 05/09/2025
- Robbie Marcus from JP Morgan set a target price of $7.0 on 05/09/2025
- Frank Takkinen from Lake Street set a target price of $14.0 on 04/08/2025
- William Plovanic from Canaccord Genuity set a target price of $18.0 on 04/08/2025
$CVRX Insider Trading Activity
$CVRX insiders have traded $CVRX stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CVRX stock by insiders over the last 6 months:
- KIRK G. NIELSEN has made 4 purchases buying 198,779 shares for an estimated $1,037,141 and 0 sales.
- KEVIN HYKES (PRES & CEO) purchased 5,000 shares for an estimated $24,200
- MUDIT K. JAIN has made 2 purchases buying 1,650 shares for an estimated $7,774 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CVRX Hedge Fund Activity
We have seen 49 institutional investors add shares of $CVRX stock to their portfolio, and 38 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EMERALD ADVISERS, LLC removed 590,850 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $3,474,198
- JPMORGAN CHASE & CO removed 503,327 shares (-80.1%) from their portfolio in Q1 2025, for an estimated $6,155,689
- LORD, ABBETT & CO. LLC added 396,763 shares (+inf%) to their portfolio in Q1 2025, for an estimated $4,852,411
- EMERALD MUTUAL FUND ADVISERS TRUST removed 369,672 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $2,173,671
- PARKMAN HEALTHCARE PARTNERS LLC added 308,348 shares (+33.5%) to their portfolio in Q1 2025, for an estimated $3,771,096
- CITADEL ADVISORS LLC added 255,043 shares (+inf%) to their portfolio in Q1 2025, for an estimated $3,119,175
- JONES FINANCIAL COMPANIES LLLP added 209,252 shares (+inf%) to their portfolio in Q1 2025, for an estimated $2,559,151
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
